Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF8 antibody

This Mouse Monoclonal antibody specifically detects TNFRSF8 in FACS, IHC and IF. It exhibits reactivity toward Human.
Catalog No. ABIN6938618
$640.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for TNFRSF8 antibody (ABIN6938618)

Target

See all TNFRSF8 Antibodies
TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

Reactivity

  • 242
  • 60
  • 31
Human

Host

  • 149
  • 113
  • 14
  • 7
  • 6
  • 1
  • 1
Mouse

Clonality

  • 182
  • 107
  • 2
Monoclonal

Conjugate

  • 110
  • 23
  • 21
  • 20
  • 12
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
This TNFRSF8 antibody is un-conjugated

Application

  • 145
  • 97
  • 81
  • 46
  • 43
  • 34
  • 28
  • 27
  • 14
  • 7
  • 7
  • 6
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunofluorescence (IF)

Clone

Ki-1-779
  • Purpose

    CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) Antibody

    Specificity

    Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1. CD30 is synthesized as a 90kDa precursor, which is processed in the Golgi complex into a membrane-bound phosphorylated mature 105/120kDa glycoprotein. In Hodgkin's disease, CD30/Ki-1 antigen is expressed by mononuclear-Hodgkin and multinucleated Reed-Sternberg cells. It is also expressed by the tumor cells of a majority of anaplastic large cell lymphomas as well as by a varying proportion of activated T and B cells. This MAb distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. About one third of the Ki-1 positive lymphomas lack the leukocyte common antigen (CD45).

    Cross-Reactivity (Details)

    Human.

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant human TNFRSF8 protein

    Isotype

    IgG1, kappa
  • Application Notes

    Known_Application: Flow Cytometry (1-2ug/million cells); Immunofluorescence (1-2ug/ml); Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 1mM EDTA, pH 7.5-8.5, for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: Hodgkin's lymphoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

    Alternative Name

    TNFRSF8

    Background

    CD30L receptor, Cytokine receptor CD30, Ki-1 antigen, Lymphocyte activation antigen CD30, Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)

    Hodgkin's lymphoma.

    Molecular Weight

    105-120kDa

    Gene ID

    943, 1314

    UniProt

    P28908
You are here:
Chat with us!